Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Radiation Injuries × Oxaliplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 74 Stomach Neoplasms 49 Rectal Neoplasms 41 Colonic Neoplasms 38 Pancreatic Neoplasms 17 Neoplasms 14 Neoplasm Metastasis 11 Carcinoma, Hepatocellular 10 Lymphoma, Large B-Cell, Diffuse 9 Cholangiocarcinoma 8 Adenocarcinoma Of Esophagus 8 Adenocarcinoma 8 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Esophageal Neoplasms 5 Esophageal Squamous Cell Carcinoma 4 Gallbladder Neoplasms 3 Biliary Tract Neoplasms 3 Neurotoxicity Syndromes 2 Lymphoma, Extranodal NK-T-Cell 2 Lymphoma 2 Gastrointestinal Neoplasms 2 Gastrointestinal Diseases 2 Colorectal Adenocarcinoma 2 Resectable Colon Cancer 1 Rectal Diseases 1 Radiation Injuries 1 Peritoneal Neoplasms 1 Patient Compliance 1 Pathologic Complete Response 1 Paresthesia 1

Interventions

Radiotherapy 5 Carboplatin 3 Paclitaxel 2 Donepezil 2 Cisplatin 2 sargramostim 1 cevimeline 1 beta Carotene 1 alpha-Tocopherol 1 Zinc Sulfate 1 Vortioxetine 1 Vitamin E 1 Standard of Care 1 Sodium Chloride 1 Salts 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiosurgery 1 Oxygen 1 Oxaliplatin 1 Meditation 1 Hyperbaric Oxygenation 1 Glutamine 1 G(M1) Ganglioside 1 Filgrastim 1 Etoposide 1 Erythropoietin 1 Epoetin Alfa 1 Dexamethasone 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02121405 2022-05-11

PSSR

Zhejiang University

Phase 3 Suspended

Gastrointestinal

Radiation Injuries, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡